Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?
about
Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.Depression and Chronic Liver Diseases: Are There Shared Underlying Mechanisms?Association Between Elevated Liver Enzymes and Metabolic Syndrome Among Thai Adults.Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.Treatment options for nonalcoholic Fatty liver diseaseClinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease.Genetic variant I148M in PNPLA3 is associated with the ultrasonography-determined steatosis degree in a Chinese populationHypertension and fatty liver: guilty by association?Non-alcoholic fatty liver disease: The diagnosis and management.A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with Non-alcoholic fatty liver disease.Obesity and air pollution: global risk factors for pediatric non-alcoholic fatty liver disease.Probable NAFLD, by ALT levels, and diabetes among Filipino-American women.Systematic review: geographical and ethnic differences in gastro-oesophageal reflux disease.Right ventricular function and its relationship with grade of hepatosteatosis in non-alcoholic fatty liver disease.A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease.Modulation Effect of Peroxisome Proliferator-Activated Receptor Agonists on Lipid Droplet Proteins in Liver.An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia.Ethanol Production by Selected Intestinal Microorganisms and Lactic Acid Bacteria Growing under Different Nutritional Conditions.Visceral fat thickness predicts fatty liver in Koreans with type 2 diabetes mellitusInhibition of LXRα/SREBP-1c-Mediated Hepatic Steatosis by Jiang-Zhi GranuleThe Prevalence of Metabolic Syndrome In Non-alcoholic Fatty Liver Disease; A Population-Based Study.An open-label randomized control study to compare the efficacy of vitamin e versus ursodeoxycholic acid in nondiabetic and noncirrhotic Indian NAFLD patients.Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes.Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system.Diagnostic Value of CK-18, FGF-21, and Related Biomarker Panel in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.Effect of liver cirrhosis on long-term outcomes after acute respiratory failure: A population-based study.Hepatitis B virus infection and metabolic syndrome: fact or fiction?Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines.Prevalence, severity, and risk factors of symptomatic gastroesophageal reflux disease among employees of a large hospital in northern India.A study of gender-wise risk association between fatty liver and metabolic syndrome components (Asia-Pacific criteria) in a South Indian urban cohort.Current and novel therapies for the treatment of nonalcoholic steatohepatitis.Relationship of hepatic steatosis and alanine aminotransferase with coronary calcification.Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study.Mean platelet volume in biopsy-proven non-alcoholic fatty liver disease.Visceral fat and insulin resistance as predictors of non-alcoholic steatohepatitis.Significant correlations between severe fatty liver and risk factors for metabolic syndrome.Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology - a prospective study.Novel non-alcoholic steatohepatitis model with histopathological and insulin-resistant features.Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease.Evaluation of safety for hepatectomy in a novel mouse model with nonalcoholic-steatohepatitis.
P2860
Q30389752-93482407-25BC-47EE-A620-A4662E973E88Q33645706-B003AB07-EF6D-4380-9E8F-B6DDCF0730CDQ34065848-728C119B-5BFC-4ADE-85BE-05BF4335AB94Q34099171-AD8F6CE8-D7C8-4406-A57E-487F70615936Q34156317-3D4292C4-D169-41F3-A394-52B029574F42Q34382683-464FCE43-E58A-4449-A925-6436EC1253D2Q34487178-87BDB6E5-B04F-4ABC-9E1B-50C3AF391BC0Q34608817-84C0C418-15CA-486B-AE78-148AEFA93238Q35543956-CE774656-BC21-4D8B-AE24-FD4E939C4B3AQ35584098-EB255790-2260-48B7-8414-555F978B3073Q35603803-6078B7D3-E400-41D8-A8B0-A760F55D4E7CQ35882617-C564892E-4E5C-46C6-BCA8-9817BA7C67FFQ35893203-D0A45637-52A2-40F5-AE94-926561C65C0FQ35962132-6D9F7259-0C43-47BB-AB4A-C6C8D7F704CAQ36172470-3CA30EAA-D8B3-4E3F-9889-2F74720309C7Q36386635-ABA61163-BE85-48A0-9B67-CC62FB4691DFQ36405031-C7CEF024-79F8-45A1-82DA-F6C1EDFC9989Q36519408-8BB2F470-A8E0-4736-BBC6-3E9542944DCFQ36854185-91B2433E-2354-4C06-AA19-2602B63B2F9AQ36896403-E68DFD1B-CD22-400F-BFE4-4E1912A92AE1Q36948009-59C7C2C2-A46F-41DA-B545-22BE06E61985Q36981317-C3ADEA06-93EE-4421-B3B3-38F31E7C6346Q37261934-B7AC8692-940F-4B3E-A97A-5445B0365031Q37610005-913EEF2B-D326-426F-88DC-AD9C67052B77Q37689828-C8CADD1C-78A0-457C-BE9B-CDA4C6B61BAEQ37730888-66A81825-30CA-4D76-A0FB-BE3FBBD629E8Q38236996-ECAC4BE9-6C1F-49C9-89C4-E691B2CAE6DCQ39800763-4F09209F-4BFC-4568-AAAA-71BC5DD42417Q39958225-C8221134-C254-414B-9C21-2255F834D227Q40248747-F41B544A-BD33-471E-9CF6-F698A6943D3BQ41832154-7C7E7489-F88B-4386-9E17-E81B101D25E8Q42852911-5FC7509E-DA6D-4F58-AB25-99C6BA5FC4DFQ43581539-B6F6CA61-05E9-4061-A519-B7A6318A6569Q45789410-47B4E3CB-7188-4C4B-9364-6ACA207DBEE6Q46256534-CD0CDB35-83D7-4037-B3C9-12F7DF232185Q46887438-88BF01C1-C92F-41E3-86EF-BCF21F0AD50FQ47163245-7DBA65F7-E354-46E8-912B-3E47DA1D98E7Q47662104-BC7C4432-D0BD-4D98-8EE5-4F8B6C85CEDFQ48032403-816AC36C-20A4-4A57-9E27-EDDABD607385Q52717218-A84A3715-8C81-48C7-BCFE-04D8E58DD119
P2860
Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?
@ast
Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?
@en
type
label
Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?
@ast
Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?
@en
prefLabel
Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?
@ast
Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?
@en
P2860
P1476
Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?
@en
P2093
Geoffrey C Farrell
Jacob George
P2860
P304
P356
10.1111/J.1440-1746.2003.03252.X
P577
2004-04-01T00:00:00Z